Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy? (Q49022172)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 July 2011

Language	Label	Description	Also known as
English	Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy?	scientific article published on 16 July 2011

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21779816%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy? (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21779816%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

0 references

chronic heart failure

1 reference

based on heuristic

inferred from title

Lutz Frankenstein

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21779816%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

9

object named as

Hugo A Katus

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21779816%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Jennifer Franke

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21779816%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Dieter Schellberg

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21779816%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Amer Bajrovic

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21779816%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Jan Sebastian Wolter

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21779816%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Philipp Ehlermann

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21779816%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Andreas O Doesch

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21779816%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Manfred Nelles

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21779816%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Christian Zugck

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21779816%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

16 July 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21779816%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Clinical Research in Cardiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21779816%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

100

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21779816%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21779816%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1059-1067

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21779816%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

https://scigraph.springernature.com/pub.10.1007/s00392-011-0340-1

0 references

Long-term trends in the incidence of heart failure after myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Survival after the onset of congestive heart failure in Framingham Heart Study subjects

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Physicians' survival predictions for patients with acute congestive heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Elevated B-type natriuretic peptide levels in patients with nonischemic cardiomyopathy predict occurrence of arrhythmic events

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

B-type natriuretic peptide - a biomarker for all seasons?

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Raised B-type natriuretic peptide predicts implantable cardioverter-defibrillator therapy in patients with ischaemic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

NT-proBNP and BNP: biomarkers for heart failure management

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Inflammation increases NT-proBNP and the NT-proBNP/BNP ratio.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Incremental predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide for short-term recurrence in atrial fibrillation ablation.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Variability of N-terminal probrain natriuretic peptide in stable chronic heart failure and its relation to changes in clinical variables.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

N-Terminal-proBNP (NT-proBNP) as an indicator of cardiac dysfunction. A study in patients presenting with suspected cardiac disorders.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Prognosis of decompensated heart failure patients with preserved systolic function is predicted by NT-proBNP variations during hospitalization.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Long-term clinical variation of NT-proBNP in stable chronic heart failure patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Lifetime Risk for Developing Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Long-Term Trends in the Incidence of and Survival with Heart Failure

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0340-1

21 January 2018

Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a β-blocker: Results from the Carvedilol Or Metoprolol European Trial (COMET) trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21779816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Deve

1 reference

https://pubmed.ncbi.nlm.nih.gov/21779816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serial NT-proBNP measurements for risk stratification of patients with decompensated heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/21779816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/21779816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biomarker responses during and after treatment with nesiritide infusion in patients with decompensated chronic heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/21779816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic value of individual NT-proBNP values in chronic heart failure does not change with advancing age

1 reference

https://pubmed.ncbi.nlm.nih.gov/21779816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Area under ROC curve, sensitivity, specificity of N-terminal probrain natriuretic peptide in predicting mortality in various subsets of patients with ischemic heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21779816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)

1 reference

https://pubmed.ncbi.nlm.nih.gov/21779816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/21779816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

1 reference

https://pubmed.ncbi.nlm.nih.gov/21779816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00392-011-0340-1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21779816%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21779816%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49022172&oldid=1541556757"